Clal Biotechnology reported ILS14.69M in Current Assets for its fiscal quarter ending in December of 2023.


Current Assets Change Date
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 97.64M 8.36M Jun/2025
Life Technologies USD 87.49M 5.54M Jun/2025
RedHill Biopharma USD 11.91M 3.79M Dec/2024